Advertisement

pp 1-23 | Cite as

Developments in Artificial Platelet and Erythroid Transfusion Products

  • Neslihan MericEmail author
  • Gulen Guney Esken
  • Merve Uslu
  • Fatih KocabasEmail author
Chapter
Part of the Advances in Experimental Medicine and Biology book series

Abstract

Platelet and blood transfusions have vital importance to the lives of many patients. Platelet transfusions are a life-saving intervention by reducing risk of bleeding in thrombocytopenic patients. Due to the short shelf life of platelets and their limited availability, researchers have developed various platelet transfusion production technologies. Understanding the cellular and biophysical mechanisms of platelet release is particularly important for development of platelet transfusion products (PTPs) and to translate them to clinical applications in patients requiring platelet infusion. Similarly, due to donor dependence and increased clinical need of blood transfusions, studies on the erythroid transfusion products (ETPs) have recently gained momentum. This led to development of ETP technologies involving differentiation of stem cells to fully functional erythrocytes in vitro. During megakaryopoiesis or erythropoiesis, various stimulatory factors, growth factors, transcription factors, and biophysical conditions have been shown to play a crucial role in the formation final blood products. Thus, understanding of the in vivo mechanisms of platelet release and erythrocyte maturation is particularly important for mimicking these conditions in vitro. This review focuses on latest and up-to-date information about the innovations in PTP and ETP technologies. We also discuss some of the recent fundamental findings that have changed our understanding of in vivo platelet release and blood formation.

Graphical Abstract

Human bone marrow acts as a source of cells required for erythropoiesis and megakaryopoeiesis. Understanding of molecular mechanism and physiology of these vital and curitial events allowed us to mimic these conditions ex vivo and to develop artificial platelet and erythroid transfusion production technologies.

Keywords

Erythroid transfusion products Erythropoiesis ETPs Hematopoietic stem cells Megakaryocytopoiesis Megakaryopoeiesis Platelet transfusion products 

Abbreviations

ABI

Aurora B Inhibitor

ADSC

Adipose Derived Stem Cells

BFU-MK

Burst Forming Unit Megakaryocyte

BM

Bone Marrow

CFU-GEMM

Colony Forming Unit – granulocyte, erythrocyte, monocyte, megakaryocyte

CFU-Mk

Colony Forming Unit Megakaryocyte

CMP

Common Myeloid Progenitor

CMPs

Common Myeloid Progenitors

DMS

Demarcation Membrane System

ECM

Extracellular Matrix

ESC

Embryonic Stem Cell

ES-sacs

Embryonic Stem Cell–Derived Sacs

ETPs

Erythroid Transfusion Products

FLI1

Friend Leukemia Integration 1

GATA1

GATA binding protein 1

GPV

Glycoprotein V

HDFs

Human Dermal Fibroblasts

hESCs

Human Embryonic Stem Cells

hiPSCs

Human Induced Pluripotent Stem Cells

HPC

Hematopoietic Progenitor Cells

HSC

Hematopoietic Stem Cell

hTERT

Human telomerase reverse transcriptase

IL-1α

Interleukin 1 alpha

MAPK

Mitogen Activated Protein Kinase

Meis1

Myeloid ectopic viral integration site 1

MEP

Megakaryocyte Erythroid Progenitor

Mk

Megakaryocyte

MKP

Megakaryocyte Progenitor

Mks

Megakaryocytes

NF-E2

Nuclear Factor Erythroid 2

PB

Peripheral Blood

PDGF

Platelet Derived Growth Factor

PI

Phosphatidylinositol

PTPs

Platelet Transfusion Products

RBCs

Red Blood Cells

RRI

Rho Rock inhibitor

RUNX1

Runt related transcription factor 1

SCF

Stem Cell Factor

SDF-1

Stromal-Derived Factor-1

SI

Src Inhibitor

STAT1

Signal Transducer and Activator of Transcription 1

TAL-1

T-cell Acute Lymphocytic Leukemia Protein 1

TGF-β

Transforming Growth Factor-Beta

TPO

Thrombopoietin

UCB

Umbilical Cord Blood

VEGF

Vascular Endothelial Growth Factor

vWF

von Willebrand Factor

Notes

Acknowledgments

FK has been supported by funds provided by the European Commission Co-Funded Brain Circulation Scheme by The Marie Curie Action COFUND of the 7th. Framework Programme (FP7) (115C039), The Scientific and Technological Research Council of Turkey (TÜBİTAK) [grant numbers 115S185, 215Z069, 215Z071,and 216S317], The Science Academy Young Scientist Award Program (BAGEP-2015, Turkey), The International Centre for Genetic Engineering and Biotechnology – ICGEB 2015 Early Career Return Grant [grant number CRP/TUR15-02_EC], Medicine for Malaria Venture MMV Pathogenbox Award (Bill and Melinda Gates Foundation), Gilead Sciences International Hematology & Oncology program, Gilead ile Hayat Bulan Fikirler, and ERA-Net CVD program (118S929). We apologize whose work could not be discussed in this review due to size limitations. All authors declare that they have no conflicts of interest concerning this work.

References

  1. Abbonante V et al (2017) A new path to platelet production through matrix sensing. Haematologica 102(7):1150–1160Google Scholar
  2. Aguilar A et al (2016) Importance of environmental stiffness for megakaryocyte differentiation and proplatelet formation. Blood 128(16):2022–2032Google Scholar
  3. Aksoz M et al (2018) c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression. Curr Cancer Drug Targets 19(6):479–494Google Scholar
  4. Alexander WS et al (1996) Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 87(6):2162–2170Google Scholar
  5. Arai F et al (2004) Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118(2):149–161Google Scholar
  6. Avanzi MP, Mitchell WB (2014) Ex vivo production of platelets from stem cells. Br J Haematol 165(2):237–247Google Scholar
  7. Avanzi MP et al (2012) Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis. Transfusion 52(11):2406–2413Google Scholar
  8. Avecilla ST et al (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 10(1):64–71Google Scholar
  9. Azcoitia V et al (2005) The homeodomain protein Meis1 is essential for definitive hematopoiesis and vascular patterning in the mouse embryo. Dev Biol 280(2):307–320Google Scholar
  10. Baigger A, Blasczyk R, Figueiredo C (2017) Towards the manufacture of megakaryocytes and platelets for clinical application. Transfus Med Hemother 44(3):165–173Google Scholar
  11. Belaoussoff M, Farrington SM, Baron MH (1998) Hematopoietic induction and respecification of A-P identity by visceral endoderm signaling in the mouse embryo. Development 125(24):5009–5018Google Scholar
  12. Bertino AM et al (2003) Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion 43(7):857–866Google Scholar
  13. Blin A et al (2016) Microfluidic model of the platelet-generating organ: beyond bone marrow biomimetics. Sci Rep 6:21700Google Scholar
  14. Bluteau D et al (2009) Regulation of megakaryocyte maturation and platelet formation. J Thromb Haemost 7(Suppl 1):227–234Google Scholar
  15. Bluteau O et al (2013) Developmental changes in human megakaryopoiesis. J Thromb Haemost 11(9):1730–1741Google Scholar
  16. Boehm D, Murphy WG, Al-Rubeai M (2009) The potential of human peripheral blood derived CD34+ cells for ex vivo red blood cell production. J Biotechnol 144(2):127–134Google Scholar
  17. Briddell RA et al (1989) Characterization of the human burst-forming unit-megakaryocyte. Blood 74(1):145–151Google Scholar
  18. Broxmeyer HE (2001) Regulation of hematopoiesis by chemokine family members. Int J Hematol 74(1):9–17Google Scholar
  19. Broxmeyer HE (2014) Inhibiting HDAC for human hematopoietic stem cell expansion. J Clin Invest 124(6):2365–2368Google Scholar
  20. Bruns I et al (2014) Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med 20(11):1315–1320Google Scholar
  21. Butler JM et al (2010) Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6(3):251–264Google Scholar
  22. Cai M et al (2012) Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferation. Blood 120:335–346.  https://doi.org/10.1182/blood-2012-01-403139CrossRefGoogle Scholar
  23. Carramolino L et al (2010) Novelty and significance. Circ Res 106(7):1197–1201Google Scholar
  24. Chaurasia P, Berenzon D, Hoffman R (2011) Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells. Blood 117(17):4632–4641Google Scholar
  25. Cho J (2015) A paradigm shift in platelet transfusion therapy. Blood 125(23):3523–3525Google Scholar
  26. Choi JS, Harley BA (2016) Challenges and opportunities to harnessing the (Hematopoietic) stem cell niche. Curr Stem Cell Rep 2(1):85–94Google Scholar
  27. Choi ES et al (1995) Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 85(2):402–413Google Scholar
  28. Corash L et al (1989) Measurement of megakaryocyte frequency and ploidy distribution in unfractionated murine bone marrow. Exp Hematol 17(3):278–286Google Scholar
  29. Csaszar E, Cohen S, Zandstra PW (2013) Blood stem cell products: toward sustainable benchmarks for clinical translation. BioEssays 35(3):201–210Google Scholar
  30. Davis RE et al (1997) Localization of megakaryocytes in normal mice and following administration of platelet antiserum, 5-fluorouracil, or radiostrontium: evidence for the site of platelet production. Exp Hematol 25(7):638–648Google Scholar
  31. De Bruyn C et al (2005) Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev 14(4):415–424Google Scholar
  32. Deutsch VR, Tomer A (2006) Megakaryocyte development and platelet production. Br J Haematol 134(5):453–466Google Scholar
  33. Deutsch VR, Tomer A (2013) Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside. Br J Haematol 161(6):778–793Google Scholar
  34. Di Buduo CA et al (2015) Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies. Blood 125(14):2254–2264.  https://doi.org/10.1182/blood-2014-08-595561CrossRefGoogle Scholar
  35. Di Buduo CA, Kaplan DL, Balduini A (2017) In vitro generation of platelets: where do we stand? Transfus Clin Biol 24(3):273–276Google Scholar
  36. Ding L et al (2012) Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481(7382):457–462Google Scholar
  37. Doan PL et al (2013) Tie2(+) bone marrow endothelial cells regulate hematopoietic stem cell regeneration following radiation injury. Stem Cells 31(2):327–337Google Scholar
  38. Drachman JG, Rojnuckarin P, Kaushansky K (1999) Thrombopoietin signal transduction: studies from cell lines and primary cells. Methods 17(3):238–249Google Scholar
  39. Dunois-Larde C et al (2009) Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 114(9):1875–1883Google Scholar
  40. Dzierzak E, Philipsen S (2013) Erythropoiesis: development and differentiation. Cold Spring Harb Perspect Med 3(4):a011601Google Scholar
  41. Eto K et al (2002) Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci U S A 99(20):12819–12824Google Scholar
  42. Feng Q et al (2014) Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Rep 3(5):817–831Google Scholar
  43. Ferrer-Marin F et al (2010) Neonatal thrombocytopenia and megakaryocytopoiesis. In: Seminars in hematology. ElsevierGoogle Scholar
  44. Figueiredo C et al (2010) Generation of HLA-deficient platelets from hematopoietic progenitor cells. Transfusion 50(8):1690–1701Google Scholar
  45. Franco AT, Corken A, Ware J (2015) Platelets at the interface of thrombosis, inflammation, and cancer. Blood 126(5):582–588Google Scholar
  46. Fuentes R et al (2010) Infusion of mature megakaryocytes into mice yields functional platelets. J Clin Invest 120(11):3917–3922Google Scholar
  47. Gars E, Rafii S (2012) It takes 2 to thrombopoies in the vascular niche. Blood 120(14):2775–2776Google Scholar
  48. Gaur M et al (2006) Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost 4(2):436–442Google Scholar
  49. Gekas C, Graf T (2010) Induced pluripotent stem cell-derived human platelets: one step closer to the clinic. J Exp Med 207(13):2781–2784Google Scholar
  50. Giammona LM et al (2006) Nicotinamide (vitamin B3) increases the polyploidisation and proplatelet formation of cultured primary human megakaryocytes. Br J Haematol 135(4):554–566Google Scholar
  51. Giammona LM et al (2009) Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition. Exp Hematol 37(11):1340–1352 e3Google Scholar
  52. Giarratana MC et al (2005) Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 23(1):69–74Google Scholar
  53. Goldfarb AN (2009) Megakaryocytic programming by a transcriptional regulatory loop: a circle connecting RUNX1, GATA-1, and P-TEFb. J Cell Biochem 107(3):377–382Google Scholar
  54. Golebiewska EM, Poole AW (2015) Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev 29(3):153–162Google Scholar
  55. González-Lázaro M et al (2014) Two new targeted alleles for the comprehensive analysis of M eis1 functions in the mouse. Genesis 52(12):967–975Google Scholar
  56. Gori JL et al (2015) Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells. J Clin Invest 125(3):1243–1254Google Scholar
  57. Guerriero R et al (1995) Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood 86(10):3725–3736Google Scholar
  58. Guo Y et al (2009) c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Blood 114(10):2097–2106Google Scholar
  59. Gurney AL et al (1995) Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation. Proc Natl Acad Sci 92(12):5292–5296Google Scholar
  60. Handigund M, Cho YG (2015) Insights into platelet storage and the need for multiple approaches. Ann Clin Lab Sci 45(6):713–719Google Scholar
  61. Hisa T et al (2004) Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. EMBO J 23(2):450–459Google Scholar
  62. Hod E, Schwartz J (2008) Platelet transfusion refractoriness. Br J Haematol 142(3):348–360Google Scholar
  63. Huang H, Cantor AB (2009) Common features of megakaryocytes and hematopoietic stem cells: what’s the connection? J Cell Biochem 107(5):857–864Google Scholar
  64. Huang N et al (2016) Identification of a potent small molecule capable of regulating polyploidization, megakaryocyte maturation, and platelet production. J Hematol Oncol 9(1):136Google Scholar
  65. Ignatz M et al (2007) Umbilical cord blood produces small megakaryocytes after transplantation. Biol Blood Marrow Transplant 13(2):145–150Google Scholar
  66. Italiano J, Hartwig JH, Michelson A (2007) Megakaryocyte development and platelet formation. Platelets 2:23–44Google Scholar
  67. Itkin T et al (2016) Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature 532(7599):323Google Scholar
  68. Ivetic N et al (2016) Producing megakaryocytes from a human peripheral blood source. Transfusion 56(5):1066–1074Google Scholar
  69. Janda K et al (2010) Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment. Przegl Lek 67(3):187–191Google Scholar
  70. Jarocha D et al (2018) Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors. Blood Adv 2(6):597–606Google Scholar
  71. Jin H et al (2014) Erythropoietic potential of CD34+ hematopoietic stem cells from human cord blood and G-CSF-mobilized peripheral blood. Biomed Res Int 2014:435215Google Scholar
  72. Klinger MH, Jelkmann W (2002) Role of blood platelets in infection and inflammation. J Interf Cytokine Res 22(9):913–922Google Scholar
  73. Knaan-Shanzer S et al (2008) Phenotypic and functional reversal within the early human hematopoietic compartment. Stem Cells 26(12):3210–3217Google Scholar
  74. Kotha S et al (2018) Microvasculature-directed thrombopoiesis in a 3D in vitro marrow microenvironment. PLoS One 13(4):e0195082Google Scholar
  75. Kunisaki Y et al (2013) Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502(7473):637–643Google Scholar
  76. Kuter DJ (2002) Apoptosis in platelets during ex vivo storage. Vox Sang 83(Suppl 1):311–313Google Scholar
  77. Lambert MP et al (2013) Challenges and promises for the development of donor-independent platelet transfusions. Blood 121(17):3319–3324Google Scholar
  78. Lannutti BJ et al (2005) Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood 105(10):3875–3878Google Scholar
  79. Lasky LC, Sullenbarger B (2011) Manipulation of oxygenation and flow-induced shear stress can increase the in vitro yield of platelets from cord blood. Tissue Eng Part C Methods 17(11):1081–1088Google Scholar
  80. Lebois M et al (2016) Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling. J Thromb Haemost 14(9):1882–1887Google Scholar
  81. Lefrancais E et al (2017) The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 544(7648):105–109Google Scholar
  82. Levine RF et al (1993) Circulating megakaryocytes: delivery of large numbers of intact, mature megakaryocytes to the lungs. Eur J Haematol 51(4):233–246Google Scholar
  83. Li J, Kuter DJ (2001) The end is just the beginning: megakaryocyte apoptosis and platelet release. Int J Hematol 74(4):365–374Google Scholar
  84. Looney MR (2018) The incomparable platelet: holy alveoli! Blood 132(11):1088–1089Google Scholar
  85. Looney MR, Headley MB (2018) Live imaging of the pulmonary immune environment. Cell Immunol  https://doi.org/10.1016/j.cellimm.2018.09.007. https://www.sciencedirect.com/science/article/abs/pii/S0008874918304404
  86. Lorenzo J, Horowitz M, Choi Y (2008) Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29(4):403–440Google Scholar
  87. Lu SJ et al (2011) Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res 21(3):530–545Google Scholar
  88. Ma DC et al (2000) CD34+ cells derived from fetal liver contained a high proportion of immature megakaryocytic progenitor cells. Eur J Haematol 64(5):304–314Google Scholar
  89. Machlus KR, Italiano JE Jr (2013) The incredible journey: from megakaryocyte development to platelet formation. J Cell Biol 201(6):785–796Google Scholar
  90. Malara A et al (2011) Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A. Blood 117(8):2476–2483Google Scholar
  91. Malik J et al (2013) Erythropoietin critically regulates the terminal maturation of murine and human primitive erythroblasts. Haematologica 98(11):1778–1787Google Scholar
  92. Matsubara Y et al (2009) Generation of megakaryocytes and platelets from human subcutaneous adipose tissues. Biochem Biophys Res Commun 378(4):716–720Google Scholar
  93. Matsubara Y et al (2013) OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets. PLoS One 8(3):e58123Google Scholar
  94. Matsunaga T et al (2006) Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells 24(12):2877–2887Google Scholar
  95. Mattia G et al (2002) Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 99(3):888–897Google Scholar
  96. Maung KK, Horwitz ME (2019) Current and future perspectives on allogeneic transplantation using ex vivo expansion or manipulation of umbilical cord blood cells. Int J Hematol 110(1):50–58Google Scholar
  97. Miharada K et al (2006) Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol 24(10):1255–1256Google Scholar
  98. Miller ME et al (2016) Meis1 is required for adult mouse erythropoiesis, megakaryopoiesis and hematopoietic stem cell expansion. PLoS One 11(3):e0151584Google Scholar
  99. Moreau T et al (2016) Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming. Nat Commun 7:11208Google Scholar
  100. Mori Y et al (2015) Prospective isolation of human erythroid lineage-committed progenitors. Proc Natl Acad Sci U S A 112(31):9638–9643Google Scholar
  101. Morita H et al (1996) Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation. FEBS Lett 395(2–3):228–234Google Scholar
  102. Morrison SJ, Scadden DT (2014) The bone marrow niche for haematopoietic stem cells. Nature 505(7483):327–334Google Scholar
  103. Mostafa SS, Miller WM, Papoutsakis ET (2000) Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br J Haematol 111(3):879–889Google Scholar
  104. Nakagawa Y et al (2013) Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell–derived megakaryocytes. Exp Hematol 41(8):742–748Google Scholar
  105. Nakamura S et al (2014) Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell 14(4):535–548Google Scholar
  106. Neildez-Nguyen TM et al (2002) Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 20(5):467–472Google Scholar
  107. Nishimura S et al (2015) IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol 209(3):453–466Google Scholar
  108. Nishino T et al (2011) Ex vivo expansion of human hematopoietic stem cells by garcinol, a potent inhibitor of histone acetyltransferase. PLoS One 6(9):e24298Google Scholar
  109. Nurhayati RW, Ojima Y, Taya M (2016) Recent developments in ex vivo platelet production. Cytotechnology 68(6):2211–2221Google Scholar
  110. Ono Y et al (2012) Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf. Blood 120(18):3812–3821Google Scholar
  111. Ono-Uruga Y et al (2016) Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin. J Thromb Haemost 14(6):1285–1297Google Scholar
  112. Pallard C et al (1995) Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J 14(12):2847–2856Google Scholar
  113. Panuganti S et al (2013) Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production. Tissue Eng Part A 19(7–8):998–1014Google Scholar
  114. Pavenski K et al (2013) Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review. Transfusion 53(10):2230–2242Google Scholar
  115. Pineault N, Boisjoli G (2015) Megakaryopoiesis and ex vivo differentiation of stem cells into megakaryocytes and platelets. ISBT Sci Ser 10(S1):154–162Google Scholar
  116. Pineault N et al (2008) Characterization of the effects and potential mechanisms leading to increased megakaryocytic differentiation under mild hyperthermia. Stem Cells Dev 17(3):483–493Google Scholar
  117. Pineault N et al (2013) Ex vivo differentiation of cord blood stem cells into megakaryocytes and platelets. Methods Mol Biol 946:205–224Google Scholar
  118. Potts KS et al (2014) A lineage of diploid platelet-forming cells precedes polyploid megakaryocyte formation in the mouse embryo. Blood 124(17):2725–2729Google Scholar
  119. Proulx C et al (2004) Increased megakaryopoiesis in cultures of CD34-enriched cord blood cells maintained at 39 degrees C. Biotechnol Bioeng 88(6):675–680Google Scholar
  120. Ravasi T et al (2010) An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140(5):744–752Google Scholar
  121. Rouyez MC et al (1997) Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Mol Cell Biol 17(9):4991–5000Google Scholar
  122. Sasaki K et al (1995) TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules. Biochem Biophys Res Commun 216(1):338–347Google Scholar
  123. Sattler M et al (1995) The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp Hematol 23(9):1040–1048Google Scholar
  124. Schulze H, Shivdasani RA (2004) Molecular mechanisms of megakaryocyte differentiation. Semin Thromb Hemost 30(4):389–398Google Scholar
  125. Schuster JA et al (2012) Expansion of hematopoietic stem cells for transplantation: current perspectives. Exp Hematol Oncol 1(1):12Google Scholar
  126. Semple JW, Italiano JE Jr, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11(4):264–274Google Scholar
  127. Sharma S, Sharma P, Tyler LN (2011) Transfusion of blood and blood products: indications and complications. Am Fam Physician 83(6):719–724Google Scholar
  128. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13(12):1501–1512Google Scholar
  129. Shim M-H et al (2004) Gene expression profile of primary human CD34+ CD38lo cells differentiating along the megakaryocyte lineage. Exp Hematol 32(7):638–648Google Scholar
  130. Smith BW, Murphy GJ (2014) Stem cells, megakaryocytes, and platelets. Curr Opin Hematol 21(5):430–437Google Scholar
  131. Sniecinski I, Seghatchian J (2018) Concluding commentary on current trends to enhance the clinical safety of pediatric transfusion, focusing on prevention of untoward complications of HSC transplantation & newer strategies for improving the standards of safety/quality of stem cells expansion for cellular therapy. Transfus Apher Sci 57(3):378–383Google Scholar
  132. Socolovsky M et al (1999) Fetal anemia and apoptosis of red cell progenitors in Stat5a−/−5b−/− mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98(2):181–191Google Scholar
  133. Sullenbarger B et al (2009) Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. Exp Hematol 37(1):101–110Google Scholar
  134. Sun S et al (2001) Overexpression of cyclin D1 moderately increases ploidy in megakaryocytes. Haematologica 86(1):17–23Google Scholar
  135. Suzuki N, Mukai HY, Yamamoto M (2015) In vivo regulation of erythropoiesis by chemically inducible dimerization of the erythropoietin receptor intracellular domain. PLoS One 10(3):e0119442Google Scholar
  136. Takahashi K et al (2007) Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2(12):3081–3089Google Scholar
  137. Takayama N, Eto K (2012) Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application. Cell Mol Life Sci 69(20):3419–3428Google Scholar
  138. Takayama N et al (2008) Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111(11):5298–5306Google Scholar
  139. Takayama N et al (2010) Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207(13):2817–2830Google Scholar
  140. Tao H et al (1999) Cord blood is better than bone marrow for generating megakaryocytic progenitor cells. Exp Hematol 27(2):293–301Google Scholar
  141. Thon JN, Italiano JE (2010) Platelet formation. Semin Hematol 47(3):220–226Google Scholar
  142. Thon JN et al (2014) Platelet bioreactor-on-a-chip. Blood 124(12):1857–1867.  https://doi.org/10.1182/blood-2014-05-574913CrossRefGoogle Scholar
  143. Tijssen MR, Ghevaert C (2013) Transcription factors in late megakaryopoiesis and related platelet disorders. J Thromb Haemost 11(4):593–604Google Scholar
  144. van den Oudenrijn S, von dem Borne AE, de Haas M (2000) Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol 28(9):1054–1061Google Scholar
  145. Walasek MA, van Os R, de Haan G (2012) Hematopoietic stem cell expansion: challenges and opportunities. Ann N Y Acad Sci 1266:138–150Google Scholar
  146. Wang LD, Wagers AJ (2011) Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat Rev Mol Cell Biol 12(10):643–655Google Scholar
  147. Wang B, Zheng J (2016) Platelet generation in vivo and in vitro. Springerplus 5(1):787Google Scholar
  148. Wang J-F, Liu Z-Y, Groopman JE (1998) The α-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood 92(3):756–764Google Scholar
  149. Wang H et al (2018) MEIS1 regulates hemogenic endothelial generation, megakaryopoiesis, and thrombopoiesis in human pluripotent stem cells by targeting TAL1 and FLI1. Stem Cell Rep 10(2):447–460Google Scholar
  150. Winkelmann M, Pfitzer P, Schneider W (1987) Significance of polyploidy in megakaryocytes and other cells in health and tumor disease. Klin Wochenschr 65(23):1115–1131Google Scholar
  151. Xi J et al (2013) In vitro large scale production of human mature red blood cells from hematopoietic stem cells by coculturing with human fetal liver stromal cells. Biomed Res Int 2013:807863Google Scholar
  152. Yang H, Miller WM, Papoutsakis ET (2002) Higher pH promotes megakaryocytic maturation and apoptosis. Stem Cells 20(4):320–328Google Scholar
  153. Yu M, Cantor AB (2012) Megakaryopoiesis and thrombopoiesis: an update on cytokines and lineage surface markers. Methods Mol Biol 788:291–303Google Scholar
  154. Yucel D, Kocabas F (2018) Developments in hematopoietic stem cell expansion and gene editing technologies. Adv Exp Med Biol 1079:103–125Google Scholar
  155. Zhang Y et al (2004) Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression. Blood 103(10):3717–3726Google Scholar
  156. Zhao M et al (2014) Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nat Med 20(11):1321–1326Google Scholar
  157. Zheng J et al (2011) Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation. Cell Stem Cell 9(2):119–130Google Scholar
  158. Zivot A et al (2018) Erythropoiesis: insights into pathophysiology and treatments in 2017. Mol Med 24(1):11Google Scholar
  159. Zou J et al (2012) Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells. Ann Hematol 91(6):813–823Google Scholar
  160. Zou X et al (2017) Small molecule supplements improve cultured megakaryocyte polyploidization by modulating multiple cell cycle regulators. Biomed Res Int 2017:2320519Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Regenerative Biology Research Laboratory, Department of Genetics and Bioengineering, Faculty of EngineeringYeditepe UniversityIstanbulTurkey
  2. 2.Graduate School of Natural and Applied SciencesYeditepe UniversityIstanbulTurkey
  3. 3.Bone Marrow Transplantation CenterAnadolu Medical CenterKocaeliTurkey

Personalised recommendations